Balyasny Asset Management LLC Legend Biotech Corp Transaction History
Balyasny Asset Management LLC
- $61.9 Billion
- Q2 2025
A detailed history of Balyasny Asset Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 375,000 shares of LEGN stock, worth $12.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
375,000
Previous 200,991
86.58%
Holding current value
$12.4 Million
Previous $6.82 Million
95.16%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
237Shares Held
60MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$229 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$198 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$189 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$125 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$98.1 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.54B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...